No single strategy best for stage I follicular lymphomaCuretoday.com (press release)In the rigorously staged group, patients treated with either rituximab/chemotherapy or systemic chemo plus radiation had significantly better progression-free survival …
Regulus, Biogen Idec Partner on MS BiomarkersGenetic Engineering NewsBG-12 (dimethyl fumarate) is a small molecule immune modulator currently undergoing regulatory review. A PEGylated interferon beta-1a is currently in Phase III development for relapsi…
Clinical Oncology NewsBendamustine Impressive For LymphomasClinical Oncology NewsChicago—The combination of bendamustine and rituximab (B-R) is superior to CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine and prednisone) plus rituximab (CHOP-…
Reasons To Own AbbVie After Abbott Splits In TwoSeeking AlphaAbbott also expects Phase III results for Daclizumab in 2014. The drug is used to treat multiple sclerosis, an inflammatory disease affecting the nervous system affecting an estimated 2.1 mil…
Biovest Conducts End of Phase III Review with FDA of BiovaxID? as …4-tradersThis includes rituximab which when used as a consolidation agent (rituximab maintenance) is generally administered on a bi-monthly dosing schedule over several years resultin…
Biologics treat blood vessel diseaseDaytona Beach News-JournalWith the diagnosis of Wegener's granulomatosis, Mr. Jones was successfully treated with a Rituximab (Rituxan) IV infusion — a biologic agent — and corticosteroids. In 1936 in Breslau, …
Second Line of Defense Against RAdailyRxRituximab for rheumatoid arthritis better choice when first round of TNF inhibitors fail. People with rheumatoid arthritis are often treated with anti-TNF drugs. When these drugs fail, patients may need to switch…
R-CHOP benefits older mantle-cell lymphoma patientsMedical XpressIn older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by maintenance therapy…
R-CHOP Benefits Older Mantle-Cell Lymphoma PatientsJournal of the American Academy of Physician Assistants(HealthDay News) – In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin…
Rituximab Works for Older Mantle Cell PatientsMedPage TodayThe long-term prognosis for older patients with mantle cell lymphoma is poor. This study evaluated the results of patients 60 years of age or older with mantle cell lymphoma, randomly assigned …